Columbia Financial CEO acquires 174 stock units
The deferral-plan interests are settled in company shares upon distribution, and the report lists direct stock options with expirations through March 2, 2036.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Columbia Financial, Inc. (CLBK) President & CEO Thomas J. Kemly reported a plan-linked acquisition of 174.1040 phantom stock units on October 16, 2026, at $10.6700 per share. The Bank’s rabbi-trust trustee purchased the units on a nondiscretionary basis under the Columbia Bank Stock Based Deferral Plan; the unit interests will be settled in shares upon distribution to Kemly. The reported plan position afterward was 155,133.7031 stock units.
The report also lists direct stock options, including options on 1,444,236 common shares at a $7.1000 exercise price, expiring July 23, 2029; that tranche was fully vested and exercisable.
Insider Trade Summary
Grant/Award: 174.104 shares
Grant/Award
15 txns
Insider
Kemly Thomas J.
Role
President & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 174.104 | $10.67 | $2K |
| holding | Stock Options (right to buy) F5 | -- | -- | -- |
| holding | Stock Options (right to buy) F5 | -- | -- | -- |
| holding | Stock Options (right to buy) F6 | -- | -- | -- |
| holding | Stock Options (right to buy) F7 | -- | -- | -- |
| holding | Stock Options (right to buy) F8 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F2 | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
| holding | Common Stock F4 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 155,133.7031 shares (Indirect, By Stock-Based Deferral Plan);
Stock Options (right to buy) — 2,019,067 contracts (Direct);
Common Stock — 588,391 shares (Direct);
Common Stock — 103,581 shares (Indirect, By 401(k));
Common Stock — 91,850 shares (Indirect, By SIM);
Common Stock — 19,198 shares (Indirect, By ESOP);
Common Stock — 78,014 shares (Indirect, By SERP);
Common Stock — 13,052 shares (Indirect, By Spouse);
Common Stock — 101,371 shares (Indirect, By Stock Award III);
Common Stock — 120,318 shares (Indirect, By Stock Award IV);
Common Stock — 118,452 shares (Indirect, By Stock Award V)
Footnotes (8)
- F1. Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person.
- F2. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on March 6, 2025; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
- F3. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 3, 2028.
- F4. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 2, 2029.
- F5. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
- F6. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 6, 2025.
- F7. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 3, 2026.
- F8. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 2, 2027.
Key Figures
Phantom stock units acquired: 174.1040 units
Price per share: $10.6700
Reported plan position: 155,133.7031 stock units
+5 more
8 metrics
Phantom stock units acquired
174.1040 units
October 16, 2026; under the Columbia Bank Stock Based Deferral Plan
Price per share
$10.6700
Price associated with the phantom stock unit acquisition
Reported plan position
155,133.7031 stock units
Position following the October 16, 2026 transaction
Direct stock options, first tranche
1,444,236 underlying common shares; $7.1000 exercise price; expires July 23, 2029
Fully vested and exercisable
Direct stock options, second tranche
83,366 underlying common shares; $7.2500 exercise price; expires May 1, 2033
Fully vested and exercisable
Direct stock options, third tranche
81,769 underlying common shares; $7.5000 exercise price; expires March 6, 2034
Options granted under the 2019 Equity Incentive Plan
Direct stock options, fourth tranche
208,447 underlying common shares; $7.3800 exercise price; expires March 3, 2035
Options granted under the 2019 Equity Incentive Plan
Direct stock options, fifth tranche
201,249 underlying common shares; $8.3100 exercise price; expires March 2, 2036
Options granted under the 2019 Equity Incentive Plan
Key Terms
phantom stock, rabbi trust, Columbia Bank Stock Based Deferral Plan, non-qualified stock-based deferral plan, +2 more
6 terms
phantom stock financial
"Represents phantom stock purchased, on a non-discretionary basis"
A phantom stock is a form of compensation that gives employees or executives the benefits of stock ownership, such as the increase in stock value, without actually giving them real shares. It acts like a promise to pay the employee the equivalent value of company stock later, often as a bonus or incentive. This allows companies to motivate and reward staff without diluting ownership or transferring actual shares.
rabbi trust financial
"trustee of the Bank's rabbi trust"
A rabbi trust is a special account a company sets up to hold promised future pay for executives, like bonus or retirement money, so those employees can see there are funds earmarked for them. It matters to investors because it signals the company’s commitment to keep key people, but the money is still part of the company’s assets and can be claimed by creditors if the company goes bankrupt—think of it as a labeled jar that isn’t completely off-limits.
Columbia Bank Stock Based Deferral Plan financial
"maintained in connection with the Columbia Bank Stock Based Deferral Plan"
non-qualified stock-based deferral plan financial
"a non-qualified stock-based deferral plan"
performance-based vesting criteria financial
"specified performance-based vesting criteria"
fully vested and exercisable financial
"Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CLBK CEO Thomas J. Kemly acquire?
Thomas J. Kemly reported an acquisition of 174.1040 phantom stock units on October 16, 2026, at $10.6700 per share. The Bank’s rabbi-trust trustee purchased the units on a nondiscretionary basis under the Columbia Bank Stock Based Deferral Plan. The stock unit interests are settled in shares upon distribution to Kemly.
What stock options does Thomas J. Kemly hold in CLBK?
The report lists direct options on 1,444,236 common shares at $7.1000, expiring July 23, 2029; 83,366 at $7.2500, expiring May 1, 2033; 81,769 at $7.5000, expiring March 6, 2034; 208,447 at $7.3800, expiring March 3, 2035; and 201,249 at $8.3100, expiring March 2, 2036. The first two tranches were fully vested and exercisable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
